Impact of new European Respiratory Society/American Thoracic Society bronchodilator reversibility interpretation on asthma diagnosis in children

<p dir="ltr">Asthma is the most common chronic condition in children, affecting approximately 10%–15% of children worldwide.1 The disease, characterised physiologically by reversible airflow obstruction, is challenging to diagnose as a result of non-specific and variable symptoms1 and poor access to objective lung function tests in most care settings. In children, asthma misdiagnosis has been reported in up to 54% of cases.2 Therefore, every major asthma guideline recommends the use of objective testing to improve the accuracy of diagnosis</p>